Top Markets
Coin of the day
Beijing Biostar Pharms Co Ltd Beijing Biostar Pharms Co Ltd

Beijing Biostar Pharms Co Ltd

2563
Rangering i aksjer #21402
Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing... Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing innovative therapies for tumors. The company is dedicated to creating novel anti-cancer drugs, each secured by independent intellectual property rights. A prominent product in its portfolio is the Utidelone injection, a next-generation microtubule inhibitor produced through a unique microbial fermentation process. This enterprise was co-founded by Li Tang and Rong Guo Qiu on July 11, 2002, and operates from its headquarters in Beijing, China.
Aksjekurs
$0.44774181
Sist synkronisert: 2026-08-21
Markedsverdi
$108.23M
Endring (1 dag)
2.19%
Endring (1 år)
-61.12%
Land
CN
Handel Beijing Biostar Pharms Co Ltd (2563)

Kategori

Utbyttehistorikk for Beijing Biostar Pharms Co Ltd (2563)
Beijing Biostar Pharms Co Ltd (aksjesymbol: 2563) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Beijing Biostar Pharms Co Ltd (2563) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH